menu
    • menu

    Company profile for Calliditas Therapeutics AB

    NEW Drugs in Dev: 3
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Calliditas Therapeutics is a specialty pharmaceutical company focused on developing high value medical products for patients with significant unmet medical needs in niche indications, where the company can partially or completely participate in the commercialization. Calliditas is focused on the development and commercialization of its lead product candidate Nefecon, which has successfully completed a Phase 2b clinical trial, ...
    Calliditas Therapeutics is a specialty pharmaceutical company focused on developing high value medical products for patients with significant unmet medical needs in niche indications, where the company can partially or completely participate in the commercialization. Calliditas is focused on the development and commercialization of its lead product candidate Nefecon, which has successfully completed a Phase 2b clinical trial, as a potential new treatment for patients with inflammatory kidney disease (IgA nephropathy) who are at risk of progressing to renal failure.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Calliditas Therapeutics ABSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Kungsbron 1, C8 SE-111 22 Stockholm
    Telephone
    Telephone
    556659-9766
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.calliditas.se/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/calliditas-therapeutics-ab
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Calliditas to Present Biomarker & Post-Hoc NefIgArd Analyses
    Calliditas to Present Biomarker & Post-Hoc NefIgArd Analyses

    30 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-therapeutics-ab-to-present-exploratory-biomarker-and-post-hoc-nefigard-analyses-at-the-world-congress-of-nephrology-302728107.html

    PR NEWSWIRE
    30 Mar 2026
    Share Share
    Calliditas Reports Data On Setanaxib In Alport Syndrome at ASN
    Calliditas Reports Data On Setanaxib In Alport Syndrome at ASN

    11 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-therapeutics-reports-safety-data-for-setanaxib-in-patients-with-alport-syndrome-at-the-american-society-of-nephrology-kidney-week-302610714.html

    PR NEWSWIRE
    11 Nov 2025
    Share Share
    Calliditas Therapeutics To Present At ASN Kidney Week
    Calliditas Therapeutics To Present At ASN Kidney Week

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-therapeutics-to-present-at-the-american-society-of-nephrology-kidney-week-302603270.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    Calliditas Presented at 62nd European Renal Association Congress
    Calliditas Presented at 62nd European Renal Association Congress

    09 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calliditas-therapeutics-presented-at-the-62nd-european-renal-association-congress-302476712.html

    PR NEWSWIRE
    09 Jun 2025
    Share Share
    Calliditas To Present Four Abstracts At ASN Kidney Week 2024
    Calliditas To Present Four Abstracts At ASN Kidney Week 2024

    16 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/16/2964011/0/en/Calliditas-Therapeutics-to-Present-Four-Abstracts-at-American-Society-of-Nephrology-ASN-Kidney-Week-2024.html

    GLOBENEWSWIRE
    16 Oct 2024
    Share Share
    Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
    Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm

    16 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/delisting-of-calliditas-therapeutics-ab-publ-from-nasdaq-stockholm-302249090.html

    PR NEWSWIRE
    16 Sep 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search